FindTrial
Sign In

Predictive value of a kind of screening scale based on Nomogram to diagnose the initially detected pulmonary ground-glass nodules

Predictive value of a kind of screening scale based on Nomogram to diagnose the initially detected pulmonary ground-glass nodules

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070812
Enrollment
Unknown
Registered
2023-04-24
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer screening

Interventions

Gold Standard:Pathological biopsy
Index test:Pulmonary nodule screening scale and CTR

Sponsors

Chengdu BOE Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients were detected pulmonary ground-glass nodules on CT.

Exclusion criteria

Exclusion criteria: Patients without definite diagnosis of pathological biopsy or refuse pathological biopsy; patients loss to follow-up; patients who cannot be followed up, treated or biopsied due to advanced age, cardiopulmonary dysfunction, severe complications and other reasons.

Design outcomes

Primary

MeasureTime frame
Positive predictive value;—

Secondary

MeasureTime frame
Negative predictive value;Independent risk factors for predicting pulmonary ground-glass nodules;Cut-off point of benign and malignant nodules;—

Countries

China

Contacts

Public ContactMinhao Yu

Chengdu BOE Hospital

503071468@qq.com+86 18380556539

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026